Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GLP-1 weight-loss drugs might help protect kidneys
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes.
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
GLP-1 RA Drug Class Benefits People With SLE, Lupus Nephritis
The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.
Study Finds GLP-1 Meds Can Also Help the Kidneys
TUESDAY, Nov. 26, 2024 (HealthDay
News
) -- The potential health benefits of
GLP-1
diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the ...
Popular diabetes and obesity drugs also protect kidneys, study suggests
Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.
5h
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
2h
on MSN
Biden administration plans to expand coverage of GLP-1 drugs for Americans with Medicare & Medicaid
CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs ...
18h
on MSN
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
MedPage Today
18h
Are GLP-1 Drugs Putting an End to Bariatric Surgery?
We go into depth, covering what bariatric surgery is, who needs it, why insurance makes it so hard to get it, and, most ...
STAT
18h
Inside the telehealth-fueled GLP-1 alternative market
The new class of
GLP-1
weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...
7d
This new supplement aims to support natural GLP-1 production and gut health
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
1d
on MSN
New supplement designed specifically to battle ‘Ozempic face’ and other GLP-1 side effects
Losing face? Take heart. A new supplement promises to put an end to the emaciated aesthetic of ‘Ozempic face.’ ...
22h
on MSN
Allurion launches compounded GLP-1 program as FDA aims to end access
Allurion (ALUR) launched a new program to provide patients access to compounded weight-loss drugs Monday after months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Biden
Ozempic
Glucagon-like peptide-1
Food and Drug Administration
Wegovy
Feedback